Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Costello

Showing results (271-280 of 368) with videos related to

Pageof 37
Sort By:
Nature Communications|December 21, 2017
Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemiaElliot Stieglitz, Tali Mazor, Adam B Olshen, et al.
Neuro-Oncology|November 1, 2020
Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factorsMohith Manjunath, Jialu Yan, Yeoan Youn, et al.
Nature Reviews. Cancer|January 25, 2014
Paediatric and adult glioblastoma: multiform (epi)genomic culprits emergeDominik Sturm, Sebastian Bender, David T W Jones, et al.
Fertility and Sterility|August 17, 2023
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary SyndromeHelena J Teede, Chau Thien Tay, Joop Laven, et al.
Human Reproduction (Oxford, England)|August 14, 2023
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†Helena J Teede, Chau Thien Tay, Joop Laven, et al.
Blood|May 9, 2001
Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 lociL J Rush, Z Dai, D J Smiraglia, et al.
Neuro-Oncology|March 14, 2020
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrenceRadhika Mathur, Yalan Zhang, Matthew R Grimmer, et al.
Neuro-Oncology|August 31, 2016
Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomideMichael Wahl, Joanna J Phillips, Annette M Molinaro, et al.
Journal of Neuropathology and Experimental Neurology|September 3, 2025
3D spatial sampling to quantify morphologic heterogeneity in isocitrate dehydrogenase-wildtype glioblastomaViva Voong, Sol Beccari, Elaheh Hashemi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2021
miRNA-independent function of long noncoding pri-miRNA lociDaniel He, David Wu, Soren Muller, et al.
Pageof 37

Showing results (271-280 of 368) with videos related to

Sort By:
Pageof 37
Nature Communications|December 21, 2017
Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemiaElliot Stieglitz, Tali Mazor, Adam B Olshen, et al.
Neuro-Oncology|November 1, 2020
Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factorsMohith Manjunath, Jialu Yan, Yeoan Youn, et al.
Nature Reviews. Cancer|January 25, 2014
Paediatric and adult glioblastoma: multiform (epi)genomic culprits emergeDominik Sturm, Sebastian Bender, David T W Jones, et al.
Fertility and Sterility|August 17, 2023
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary SyndromeHelena J Teede, Chau Thien Tay, Joop Laven, et al.
Human Reproduction (Oxford, England)|August 14, 2023
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†Helena J Teede, Chau Thien Tay, Joop Laven, et al.
Blood|May 9, 2001
Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 lociL J Rush, Z Dai, D J Smiraglia, et al.
Neuro-Oncology|March 14, 2020
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrenceRadhika Mathur, Yalan Zhang, Matthew R Grimmer, et al.
Neuro-Oncology|August 31, 2016
Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomideMichael Wahl, Joanna J Phillips, Annette M Molinaro, et al.
Journal of Neuropathology and Experimental Neurology|September 3, 2025
3D spatial sampling to quantify morphologic heterogeneity in isocitrate dehydrogenase-wildtype glioblastomaViva Voong, Sol Beccari, Elaheh Hashemi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2021
miRNA-independent function of long noncoding pri-miRNA lociDaniel He, David Wu, Soren Muller, et al.
Pageof 37